On the basis of the increased risks of pulmonary hypertension and death related to high tricuspid regurgitant (TR) velocity and plasma Brain Natriuretic Peptides (NT-proBNP) concentrations, the American Thoracic Society recommend annual screening of these values for SCD patients [5]. The gene discussed is NPPB; the disease is pulmonary arterial hypertension.